Genetic Analysis
Genetic Analysis AS: Genetic Analysis AS announces CE-IVDR marking for its GA-map® Sample Collection Kit
The GA-map® Sample Collection Kit is now commercially available and will also be offered as a stand-alone product for researchers and laboratories in need of fecal collection sampling, as well as a direct-to-consumer setting. The GA-map® Sample Collection Kit has been designed to be used in conjunction with the GA-map® Dysbiosis Test, a CE-marked probe-based gut microbiota test that can diagnose and characterize dysbiosis in patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). The market for Microbiome analysis is growing rapidly, and GA is changing the market by lowering the entry barrier for smaller labs to start microbiome testing. The new collection kit is a great complementary product to the Company’s offering to the research lab customers.
CEO Ronny Hermansen comments:
”The CE-IVD marking of the GA-map® Sample Collection Kit demonstrates that the product meets the high standards of quality, safety, and performance required by the In Vitro Diagnostic Regulation (EU) 2017/746. Having acquired the certification, we can now expand our commercialization efforts to a significantly broader customer base, thereby enhancing our sales potential and at the same time strengthening our presence in the microbiome analysis field. We believe that our products can make a difference in the diagnosis and management of patients with gut-related disorders, and we look forward to bringing them to more markets and regions in the near future.”
For further information, please contact:
Ronny Hermansen, CEO
E-mail: rh@genetic-analysis.com
Eilert Aamodt, CFO
E-mail: ea@genetic-analysis.com
Datum | 2024-02-26, kl 08:00 |
Källa | Cision |
![](https://static.allaaktier.se/ads/hand-waving-2.png)